.After antibody-drug conjugate (ADC) expert Seagen was actually sold to Pfizer in 2014 for a whoppin...
.On the heels of a phase 3 win that failed to make an impression on financiers, Ironwood Pharmaceuti...
.Don't stop Monte Rosa Rehabs right now. The Boston-based biotech is enjoying after authorizing a ha...
.Welcome to this week's Chutes & Ladders, our roundup of considerable management hirings, shootin...
.Celebrating his company's upsized going public (IPO), Septerna chief executive officer Jeffrey Fine...
.AbbVie has come back to the source of its own antipsychotic giant Vraylar looking for yet another r...
.GenSight Biologics is actually full weeks away from losing loan. Again. The biotech simply has enou...
.Monopar Therapies is recuperating a medication coming from the dump of AstraZeneca's unusual diseas...
.Along with new information out on Arcus Biosciences' speculative HIF-2a inhibitor, one group of ana...
.After forming a gene treatment alliance along with Dyno Therapies in 2020, Roche is back for even m...